Hilltelligence markHilltelligence
Senate119th Congress · 2nd Session· Apr 23, 2026

Roll Call 103

Amendment Rejected

On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)

To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

What this vote was on

Procedural — this roll call is not tied to a bill or nomination (previous question, adjournment, quorum, and similar motions).

View the official record ↗

Yea48Nay50Not voting2
Democrats
44 – 0
Republicans
2 – 50
Independents
2 – 0

Member-by-member (100)

Yea (48)

Nay (50)

Present (0)

None

Not voting (2)